ArticleCancers2021

Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.

Vikas Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.